Surgepays Stock Alpha and Beta Analysis
| SURG Stock | USD 1.92 0.19 9.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Surgepays. It also helps investors analyze the systematic and unsystematic risks associated with investing in Surgepays over a specified time horizon. Remember, high Surgepays' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Surgepays' market risk premium analysis include:
Beta 2.47 | Alpha (0.04) | Risk 6.21 | Sharpe Ratio 0.0691 | Expected Return 0.43 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Surgepays |
Surgepays Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Surgepays market risk premium is the additional return an investor will receive from holding Surgepays long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Surgepays. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Surgepays' performance over market.| α | -0.04 | β | 2.47 |
Surgepays expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Surgepays' Buy-and-hold return. Our buy-and-hold chart shows how Surgepays performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Surgepays Market Price Analysis
Market price analysis indicators help investors to evaluate how Surgepays stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Surgepays shares will generate the highest return on investment. By understating and applying Surgepays stock market price indicators, traders can identify Surgepays position entry and exit signals to maximize returns.
Surgepays Return and Market Media
The median price of Surgepays for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 is 1.68 with a coefficient of variation of 9.15. The daily time series for the period is distributed with a sample standard deviation of 0.15, arithmetic mean of 1.69, and mean deviation of 0.12. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 100 shares by Schurfeld Richard Earl of Surgepays at 0.03 subject to Rule 16b-3 | 09/09/2024 |
2 | Disposition of 22900 shares by Schurfeld Richard Earl of Surgepays at 0.0092 subject to Rule 16b-3 | 09/11/2024 |
3 | Acquisition by Schurfeld Richard Earl of 1800 shares of Surgepays at 1.5 subject to Rule 16b-3 | 09/13/2024 |
4 | Disposition of tradable shares by Evers Anthony George of Surgepays at 3.0 subject to Rule 16b-3 | 09/16/2024 |
5 | Discretionary transaction by Schurfeld Richard Earl of tradable shares of Surgepays subject to Rule 16b-3 | 09/23/2024 |
6 | Acquisition by Evers Anthony George of 66667 shares of Surgepays subject to Rule 16b-3 | 10/01/2024 |
7 | Disposition of 36667 shares by Evers Anthony George of Surgepays at 1.5376 subject to Rule 16b-3 | 10/02/2024 |
8 | Meta Platforms Beats Q3 Earnings and Revenue Estimates | 10/30/2024 |
9 | Disposition of 36667 shares by Evers Anthony George of Surgepays at 1.6 subject to Rule 16b-3 | 11/01/2024 |
10 | Disposition of 31700 shares by Kevin Cox of Surgepays at 1.595 subject to Rule 16b-3 | 11/04/2024 |
11 | SurgePays Announces Third Quarter 2024 Earnings Release and Conference Call | 11/05/2024 |
12 | SurgePays, Inc. Q3 2024 Earnings Call Transcript | 11/13/2024 |
13 | SurgePays CEO Kevin Brian Cox sells 50,561 in stock | 11/15/2024 |
14 | SurgePays Teams Up With ATT For Affordable Wireless Solutions Nationwide Stock Gains | 11/21/2024 |
15 | Memphis-area company announces multiyear deal with ATT | 11/22/2024 |
16 | Acquisition by Weisberg Laurie of 301 shares of Surgepays at 1.83 subject to Rule 16b-3 | 11/25/2024 |
17 | SurgePays Integrates its ClearLine Marketing Platform with PAX Smart Payment Terminals | 11/26/2024 |
About Surgepays Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Surgepays or other stocks. Alpha measures the amount that position in Surgepays has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 8.84 | 0.33 | 8.03 | 7.63 | Receivables Turnover | 15.71 | 13.17 | 14.38 | 16.34 |
Surgepays Upcoming Company Events
As portrayed in its financial statements, the presentation of Surgepays' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Surgepays' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Surgepays' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Surgepays. Please utilize our Beneish M Score to check the likelihood of Surgepays' management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Surgepays
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Surgepays Backtesting, Surgepays Valuation, Surgepays Correlation, Surgepays Hype Analysis, Surgepays Volatility, Surgepays History and analyze Surgepays Performance. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Surgepays technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.